Basel Medical Group Ltd is projected to rise to $8.15 by 2027, a +23% move from its current price of $6.61. BMGL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $6.16 | $6.61 | $7.09 | +0.07% |
| Jul 14 | $5.99 | $6.61 | $7.31 | +0.14% |
| Jul 15 | $5.86 | $6.62 | $7.48 | +0.22% |
| Jul 16 | $5.75 | $6.62 | $7.63 | +0.29% |
| Jul 17 | $5.66 | $6.63 | $7.76 | +0.36% |
| Jul 18 | $5.58 | $6.63 | $7.88 | +0.43% |
| Jul 19 | $5.51 | $6.64 | $8.00 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.51 | $6.64 | $8.00 | +0.50% |
| Week 2 | $5.13 | $6.67 | $8.68 | +1.01% |
| Week 3 | $4.86 | $6.71 | $9.26 | +1.52% |
| Week 4 | $4.64 | $6.74 | $9.78 | +2.03% |
| Week 5 | $4.46 | $6.77 | $10.28 | +2.54% |
| Week 6 | $4.31 | $6.81 | $10.75 | +3.06% |
| Week 7 | $4.18 | $6.84 | $11.20 | +3.58% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services.
In addition, its services include consultation, medical diagnosis, and medical and surgical treatments.
The company was incorporated in 2023 and is headquartered in Singapore.
BMGL is a healthcare company focused on orthopedic and neurosurgical services in Singapore.
The stock trades at $6.62 per share, with a market capitalization of $10.36M and a rank of 5127.
Forecasts show a bullish price path through 2050. From 2027 onward, the average price rises to $8.13 in 2027 (ROI 22.9%), $9.85 in 2028 (ROI 48.8%), $10.60 in 2029 (ROI 60.2%), and $9.34 in 2030 (ROI 41%), culminating in $22.77 in 2050 (ROI 243.9%).
A major floor 92.7% below — a decisive break under it would weaken the trend.
The nearest floor, 11.9% below — buyers have tended to step in here.
The nearest ceiling, 26.4% above — a clean break opens room to run.
A major ceiling 97.0% above — clearing it would confirm fresh momentum.
Key BMGL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BMGL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.49 | Buy | $6.61 | Sell |
| MA 10 | $6.85 | Sell | $6.37 | Buy |
| MA 20 | $5.01 | Buy | $5.29 | Buy |
| MA 50 | $2.38 | Buy | $3.30 | Buy |
| MA 100 | $1.50 | Buy | $2.22 | Buy |
| MA 200 | $1.30 | Buy | $1.87 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.79 | Neutral |
| Stoch RSI (14) | 8.79 | Buy |
| CCI (20) | 40.15 | Neutral |
| Williams %R (14) | -73.94 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -4.69 | Sell |
| Bollinger %B (20,2) | 0.64 | Neutral |
| Stochastic %K (14) | 26.06 | Neutral |
| TRIX (15) | 9.24 | Buy |
| Awesome (5,34) | 3.31 | Buy |
| Ultimate (7,14,28) | 57.89 | Neutral |
| Momentum (10) | -0.11 | Sell |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 6.17 | Buy |
| ADX (14) | 39.19 | Buy |
| ATR (14) | 0.48 | Info |
The 30-day technical picture is bearish. RSI14 is 50, indicating neutral momentum.
The 30-day range runs from $4.10 to $10.69, with immediate support at $5.82 and resistance at $8.35.
SMA50 is $7.35 and SMA200 is $10.38, and annualized volatility sits at 100% within this window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.82 | $6.61 | $10.49 | 0% | Neutral | |
| $5.84 | $8.15 | $12.29 | +23% | Bullish | |
| $6.60 | $9.83 | $15.85 | +49% | Bullish | |
| $6.69 | $10.54 | $17.87 | +60% | Bullish | |
| $5.65 | $9.35 | $16.54 | +42% | Bullish | |
| $5.15 | $8.95 | $16.41 | +36% | Bullish | |
| $4.41 | $8.02 | $15.17 | +21% | Bullish | |
| $4.86 | $9.24 | $17.98 | +40% | Bullish | |
| $6.50 | $12.90 | $25.77 | +95% | Bullish | |
| $6.27 | $13.00 | $26.59 | +97% | Bullish | |
| $6.84 | $15.20 | $34.28 | +130% | Bullish | |
| $10.18 | $22.63 | $52.05 | +243% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.82 | $6.61 | $7.72 | +0.00% |
| August 2026 | $5.43 | $6.60 | $8.36 | -0.11% |
| September 2026 | $5.72 | $7.05 | $9.13 | +6.87% |
| October 2026 | $5.48 | $6.84 | $9.03 | -2.93% |
| November 2026 | $5.50 | $6.95 | $9.31 | +1.53% |
| December 2026 | $6.05 | $7.73 | $10.49 | +11.18% |
Click any year to see its month-by-month BMGL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BMGL to range from $5.82 to $10.49 through 2026. The $6.61 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The BMGL price prediction for 2027 points to an average of $8.15 (low $5.84, high $12.29) — a potential gain of +23% on today's $6.61. Momentum favours further upside here.
In 2028, BMGL is projected to trade between $6.60 and $15.85, averaging $9.83 — a potential gain of +49% from today's $6.61. That is up +21% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Basel Medical Group Ltd's 2029 outlook centres on $10.54, within a $6.69 to $17.87 range. That is up +7% on the projected 2028 average. That marks a +60% change versus current levels. Momentum favours further upside here.
By 2030, BMGL could reach as high as $16.54, with a base case around $9.35 and support toward $5.65 — roughly +42% from $6.61. Buyers look set to stay in control over this stretch.
Expect BMGL to range from $5.15 to $16.41 through 2031. The $8.95 average target implies a +36% move from current prices. That is -4% versus the projected 2030 average. Momentum favours further upside here.
The BMGL price prediction for 2032 points to an average of $8.02 (low $4.41, high $15.17) — a potential gain of +21% on today's $6.61. Buyers look set to stay in control over this stretch.
In 2033, BMGL is projected to trade between $4.86 and $17.98, averaging $9.24 — a potential gain of +40% from today's $6.61. That is up +15% on the projected 2032 average. Momentum favours further upside here.
Basel Medical Group Ltd's 2034 outlook centres on $12.90, within a $6.50 to $25.77 range. That is up +40% on the projected 2033 average. That marks a +95% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, BMGL could reach as high as $26.59, with a base case around $13.00 and support toward $6.27 — roughly +97% from $6.61. Momentum favours further upside here.
Expect BMGL to range from $6.84 to $34.28 through 2040. The $15.20 average target implies a +130% move from current prices. That is up +17% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The BMGL price prediction for 2050 points to an average of $22.63 (low $10.18, high $52.05) — a potential gain of +243% on today's $6.61. Momentum favours further upside here.
Investing $1,000 in BMGL today (≈ 151.400454 BMGL) could be worth
$3,426.48
+$2,426.48 (+243%) by 2050 · US Dollar
Based on the average projected BMGL price of $22.63 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BMGLwould be worth at today's price.
$1,000 invested in BMGL on Jul 10, 2025 (≈ 336.700333 BMGL) would be worth
$2,223.91
+$1,223.91 (+122.4%) today · 2.22× · US Dollar
Based on a BMGL entry price of $2.97 vs. today's $6.61.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.35 | $791.02 | -20.9% |
| 1 month ago | $0.587 | $11,252.13 | +1025.2% |
| 3 months ago | $0.589 | $11,213.92 | +1021.4% |
| 6 months ago | $0.647 | $10,208.66 | +920.9% |
| 1 year ago | $2.97 | $2,223.91 | +122.4% |
| All time (1.4y) ago | $4.44 | $1,487.61 | +48.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BMGL forecast.
Our base-case forecast reaches $13.00 around 2040.
Implied market cap at $13.00: $20.35M
The multi-year forecast shows bullish sentiment across most years, with meaningful upside. From 2027 onward, the average price is projected to rise: 2027 avg $8.13 (ROI 22.9%), 2028 avg $9.85 (ROI 48.8%), 2029 avg $10.60 (ROI 60.2%), and 2030 avg $9.34 (ROI 41%). Sentiment remains BULLISH across these years.
Looking further ahead, 2034 averages at $12.97 (ROI 95.9%) and 2035 at $13.05 (ROI 97.2%). The 2040 forecast averages $15.28 (ROI 130.8%) and the 2050 forecast averages $22.77 (ROI 243.9%). These are estimates, not guarantees, and are subject to change with market conditions.
Tap a question to reveal the answer.
Avg $9.34, min $5.63, max $16.53; ROI 41%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with 2027 avg $8.13 ROI 22.9% and 2050 avg $22.77 ROI 243.9%; the 2026 forecast is neutral at avg $6.62.
The forecast max price by 2050 is $52.36.
Current price is $6.62 and market cap is $10.36M.
Incorporated in 2023; headquartered in Singapore.
Basel Medical Group Ltd Community Discussion
0Share your Basel Medical Group Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.